CORZ - Core Scientific, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.60
DETAILS
HIGH:
$37.00
LOW:
$29.00
MEDIAN:
$30.00
CONSENSUS:
$31.60
UPSIDE:
25.10%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 319.0 | 510.7 | 502.4 | 640.3 | 544.5 | 60.3 | 59.5 |
| Cost of Revenue | 281.1 | 389.6 | 378.9 | 631.9 | 305.6 | 50.9 | 49.0 |
| Gross Profit | 37.9 | 121.1 | 123.5 | 8.4 | 238.9 | 9.4 | 10.5 |
| Operating Expenses | |||||||
| R&D Expenses | 0 | 11.8 | 7.2 | 27.0 | 7.7 | 5.3 | 5.5 |
| SG&A Expenses | 182.6 | 120.4 | 100.9 | 226.0 | 64.5 | 16.3 | 17.5 |
| Other Expenses | 79.9 | 8.0 | 6.4 | 1,865.0 | 0 | (5.9) | 0 |
| Operating Expenses | 262.4 | 140.3 | 114.5 | 2,118.0 | 72.2 | 15.7 | 23.0 |
| Operating Income | |||||||
| Operating Income | (224.6) | (19.2) | 9.0 | (2,109.6) | 166.6 | (6.3) | (11.7) |
| Interest Expense | 0 | 37.1 | 86.2 | 96.8 | 44.4 | 4.4 | 0.2 |
| Interest Income | 3.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | |||||||
| EBITDA | (144.4) | (1,157.0) | (63.1) | (1,840.5) | 140.8 | 1.6 | (5.6) |
| EBIT | (224.6) | (1,277.1) | (159.6) | (2,066.6) | 107.4 | (7.8) | (11.7) |
| Income Before Tax | (288.0) | (1,314.1) | (245.8) | (2,163.4) | 63.1 | (12.2) | (11.9) |
| Income Tax Expense | 0.6 | 0.9 | 0.7 | (17.1) | 15.8 | 0 | 0 |
| Net Income | (288.6) | (1,315.0) | (246.5) | (2,146.3) | 47.3 | (12.2) | (11.9) |
| Per Share Data | |||||||
| EPS (Basic) | -0.88 | -5.14 | -0.65 | -6.30 | 0.23 | -0.06 | -0.28 |
| EPS (Diluted) | -0.88 | -5.14 | -0.65 | -6.30 | 0.20 | -0.06 | -0.28 |
| Shares Outstanding | 318.1 | 255.8 | 379.9 | 340.6 | 207.3 | 379.9 | 379.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 311.4 | 836.2 | 50.4 | 15.9 | 117.9 | 8.7 | 6.7 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 1.0 | 7.2 | 3.5 | 1.7 | 1.1 | 0.3 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 584.2 | 66.7 | 24.6 | 37.4 | 250.4 | 59.9 | 1.4 |
| Total Current Assets | 895.5 | 904.0 | 97.0 | 85.1 | 756.6 | 70.9 | 11.1 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 1,401.8 | 670.8 | 593.3 | 711.6 | 599.8 | 85.2 | 81.3 |
| Goodwill | 0 | 0 | 0 | 0 | 1,055.8 | 58.2 | 58.2 |
| Intangible Assets | 0 | 0 | 2.2 | 1.7 | 8.2 | 6.7 | 4.0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 50.3 | 24.0 | 19.6 | 9.3 | 18.6 | 4.5 | 7.4 |
| Total Non-Current Assets | 1,452.1 | 694.9 | 615.1 | 722.6 | 1,682.3 | 154.7 | 151.0 |
| Total Assets | 2,347.6 | 1,598.8 | 712.2 | 807.7 | 2,438.9 | 225.6 | 162.0 |
| Current Liabilities | |||||||
| Account Payables | 126.1 | 19.3 | 154.8 | 53.6 | 11.6 | 3.1 | 7.5 |
| Short-Term Debt | 0 | 16.3 | 124.4 | 36.2 | 76.0 | 16.0 | 0.6 |
| Deferred Revenue | 127.6 | 18.1 | 9.8 | 78.2 | 141.9 | 0 | 0 |
| Other Current Liabilities | 527.7 | 69.2 | 6.8 | 1.6 | 4.4 | 47.5 | 8.7 |
| Total Current Liabilities | 781.4 | 134.6 | 488.4 | 186.8 | 320.3 | 69.6 | 19.5 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 1,060.3 | 1,074.0 | 684.1 | 0 | 652.2 | 19.9 | 2.1 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1,468.7 | 1,112.6 | 99.3 | 1,029.5 | 63.0 | 0.1 | 1.4 |
| Total Non-Current Liabilities | 2,529.0 | 2,284.4 | 820.7 | 1,030.2 | 777.4 | 22.2 | 6.7 |
| Total Liabilities | 3,310.4 | 2,419.0 | 1,309.1 | 1,217.0 | 1,097.7 | 91.9 | 26.2 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (4,146.7) | (3,735.2) | (2,420.2) | (2,173.8) | (27.4) | (74.7) | (62.5) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | (11.0) | 0 | 0 |
| Total Stockholders' Equity | (962.7) | (820.2) | (596.9) | (409.3) | 1,341.2 | 133.7 | 135.9 |
| Total Liabilities & Equity | 2,347.6 | 1,598.8 | 712.2 | 807.7 | 2,438.9 | 225.6 | 162.0 |
| Debt Metrics | |||||||
| Total Debt | 1,060.3 | 1,199.8 | 865.5 | 37.7 | 818.8 | 40.3 | 7.5 |
| Net Debt | 748.9 | 363.6 | 815.1 | 21.8 | 700.9 | 31.6 | 0.8 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (288.6) | (1,315.0) | (246.5) | (2,146.3) | 47.3 | (12.2) | (11.9) |
| Depreciation & Amortization | 68.9 | 120.1 | 96.4 | 226.1 | 33.4 | 9.4 | 6.1 |
| Stock-Based Compensation | 98.2 | 51.9 | 58.9 | 182.9 | 38.9 | 3.0 | 2.9 |
| Change in Working Capital | 524.5 | (27.6) | 551.0 | 78.6 | (49.5) | (21.1) | 5.7 |
| Other Non-Cash Items | (124.8) | 1,213.5 | (394.8) | 1,882.4 | (136.4) | (2.9) | (3.6) |
| Operating Cash Flow | 278.2 | 42.9 | 65.1 | 205.2 | (56.7) | (23.8) | (0.8) |
| Investing Activities | |||||||
| Capital Expenditure | (729) | (95.0) | (16.2) | (601.7) | (59.3) | (1.6) | (37.4) |
| Acquisitions | 0 | 0 | 0 | 10.8 | (365.2) | (13.7) | 0 |
| Purchases of Investments | (5) | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 10.8 | 0 | 0 | 0 |
| Other Investing Activities | (6.8) | (0.2) | 13.2 | (10.8) | 0.6 | 0.1 | 0.1 |
| Investing Cash Flow | (740.8) | (95.2) | (3.0) | (590.8) | (423.8) | (15.1) | (37.4) |
| Financing Activities | |||||||
| Net Debt Issuance | (10.3) | 766.9 | (41.0) | 117.7 | 613.7 | 38.1 | (0.8) |
| Stock Repurchased | 0 | 0 | 0 | (31.6) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (59.7) | (2.3) | (3.7) | 220.1 | (681.4) | 2.6 | 29.5 |
| Financing Cash Flow | (63.1) | 819.6 | (44.6) | 306.2 | 603.5 | 40.7 | 28.7 |
| Cash Position | |||||||
| Net Change in Cash | (525.6) | 767.3 | 17.5 | (79.4) | 123.0 | 1.8 | (9.5) |
| Cash at Beginning | 837.0 | 69.7 | 52.2 | 131.7 | 8.7 | 6.9 | 16.4 |
| Cash at End | 311.4 | 837.0 | 69.7 | 52.2 | 131.7 | 8.7 | 6.9 |
| Free Cash Flow | (450.8) | (52.1) | 49.0 | (396.5) | (116.0) | (25.3) | (38.2) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 319.0 | 510.7 | 502.4 | 640.3 | 544.5 | 60.3 | 59.5 |
| Gross Profit | 37.9 | 121.1 | 123.5 | 8.4 | 238.9 | 9.4 | 10.5 |
| Operating Income | (224.6) | (19.2) | 9.0 | (2,109.6) | 166.6 | (6.3) | (11.7) |
| Net Income | (288.6) | (1,315.0) | (246.5) | (2,146.3) | 47.3 | (12.2) | (11.9) |
| EPS (Diluted) | -0.88 | -5.14 | -0.65 | -6.30 | 0.20 | -0.06 | -0.28 |
| Balance Sheet | |||||||
| Cash & Equivalents | 311.4 | 836.2 | 50.4 | 15.9 | 117.9 | 8.7 | 6.7 |
| Total Assets | 2,347.6 | 1,598.8 | 712.2 | 807.7 | 2,438.9 | 225.6 | 162.0 |
| Total Debt | 1,060.3 | 1,199.8 | 865.5 | 37.7 | 818.8 | 40.3 | 7.5 |
| Stockholders' Equity | (962.7) | (820.2) | (596.9) | (409.3) | 1,341.2 | 133.7 | 135.9 |
| Cash Flow | |||||||
| Operating Cash Flow | 278.2 | 42.9 | 65.1 | 205.2 | (56.7) | (23.8) | (0.8) |
| Capital Expenditure | (729) | (95.0) | (16.2) | (601.7) | (59.3) | (1.6) | (37.4) |
| Free Cash Flow | (450.8) | (52.1) | 49.0 | (396.5) | (116.0) | (25.3) | (38.2) |